Stick With Opera Ltd ADR (OPRA). The Bull Are Alive And Well

Citigroup Global Markets, Inc. recently announced the acquisition of new stake in Opera Ltd ADR (NASDAQ:OPRA). This fresh investment now brings its stake to 3.18% valued currently at $37.38 million. In addition, Marshall Wace LLP raised its holdings by 1.01 million to 2.48 million shares. And Arrowstreet Capital LP has lifted its position by 100.60% or 0.58 million shares – to 1.15 million shares.

With over 0.45 million Opera Ltd ADR (OPRA) shares trading Friday and a closing price of $11.60 on the day, the dollar volume was approximately $5.24 million. The shares have shown a negative half year performance of -41.30% and its price on 01/12/24 lost nearly -2.93%. Currently, there are 89.22M common shares owned by the public and among those 88.63M shares have been available to trade.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The top 3 mutual fund holders in Opera Ltd ADR are Amplify Transformational Data Sha, FP Brunel Pension Partnership ACS, and Roumell Opportunistic Value Fund. Amplify Transformational Data Sha owns 0.77 million shares of the company’s stock, all valued at over $10.24 million. Roumell Opportunistic Value Fund sold -0.21 million shares to bring its total holdings to over 0.14 million shares at a value of $1.85 million. Roumell Opportunistic Value Fund now owns shares totaling to 0.16% of the shares outstanding.

Shares of Opera Ltd ADR (NASDAQ: OPRA) opened at $11.96, up $0.01 from a prior closing price of $11.95. However, the script later moved the day high at 12.08, down -2.93%. The company’s stock has a 5-day price change of -3.49% and 4.50% over the past three months. OPRA shares are trading -12.32% year to date (YTD), with the 12-month market performance up to 109.27% higher. It has a 12-month low price of $5.65 and touched a high of $28.58 over the same period. OPRA has an average intraday trading volume of 676.73K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.78%, -4.72%, and -17.80% respectively.

Institutional ownership of Opera Ltd ADR (NASDAQ: OPRA) shares accounts for 16.39% of the company’s 89.22M shares outstanding. Mutual fund holders own 1.71%, while other institutional holders and individual stakeholders account for 14.67% and — respectively.

It has a market capitalization of $1.03B and a beta (3y monthly) value of 0.77. The stock’s trailing 12-month PE ratio is 15.98, while the earnings-per-share (ttm) stands at $0.73. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.59% over the week and 5.57% over the month.

Analysts forecast that Opera Ltd ADR (OPRA) will achieve an EPS of $0 for the current quarter, $0.23 for the next quarter and $0.97 for 2024. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was $0.1 a year ago. Earnings per share for the fiscal year are expected to increase by 571.35%, and 11.04% over the next financial year.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 6 brokerage firm advisors rate Opera Ltd ADR (OPRA) as a “Strong Buy” at a consensus score of 1.00. Specifically, 6 Wall Street analysts polled rate the stock as a buy, while 0 of the 6 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the OPRA, a number of firms have released research notes about the stock. B. Riley Securities stated their Buy rating for the stock in a research note on December 14, 2023, with the firm’s price target at $20.

Most Popular

Related Posts